Acuta Capital Partners’s Krystal Biotech KRYS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-72,551	Closed	-$3.79M	–	46
2021 Q3	$3.79M	Buy	+72,551	New	+$3.79M	1.34%	24